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Abstract
Long-chain (n-3) PUFA (LC-PUFA) have been hypothesized to be beneficial in preventing pancreatic carcinogenesis, but
the associations of fish or LC-PUFA intake with pancreatic cancer found in epidemiologic studies have been controversial
and inconclusive. To estimate the overall association of LC-PUFA or fish intake with pancreatic cancer, we performed a
systematic literature search of English-language articles using PubMed and EMBASE through February 2012 and
reviewed the reference lists from retrieved articles. Prospective cohort or case-control studies that reported ratio
estimates and corresponding 95% CI for the associations of fish or LC-PUFA intake and pancreatic cancer were selected.
Independent data extraction was performed by 2 of the authors. The pooled associations were obtained by using a
random-effects model. A database was derived from 9 independent cohorts that included 1,209,265 participants (3082
events) with a mean follow-up of 9 y and 10 independent case-control studies that included 2514 cases and 18,779
controls. Comparedwith those having the lowest fish consumption, the pooled RR of pancreatic cancer was 0.98 (95%CI:
0.86, 1.12) for those who had the highest fish intake from 8 cohort studies and was 0.96 (95% CI: 0.76, 1.21) from 9 case-
control studies. We found similar results for LC-PUFA intake by combining data from 4 cohorts or 2 case-control studies.
Our results do not support an overall inverse association of fish or LC-PUFA intake with risk of pancreatic cancer. Further
studies that consider different species and preparation methods of fish, and additional adjustment for contaminants in fish,
are warranted. J. Nutr. 142: 1067–1073, 2012.
Introduction
Pancreatic cancer, one of the leading causes of cancer deaths
among both males and females (1), has become a significant
public health burden worldwide. Considering its poor prognosis
and the high mortality rate, identifying factors that may prevent
pancreatic cancer is of great public health interest and signifi-
cance (2). Because pancreatic cancer may have an inflammatory
pathogenesis (3), and long-chain (n-3) PUFA (LC-PUFA) and key
nutrients in fish which include EPA 20:5 (n-3), docosapantae-
noic acid [DPA 22:5 (n-3)], and DHA 22:6 (n-3), may have
antiinflammatory properties (4), it has been reasonably hypothe-
sized that fish or LC-PUFA intake may lower the risk of pancreatic
cancer. A series of epidemiologic studies have examined the
association of fish or LC-PUFA intake with risk of pancreatic
cancer, but findings were inconsistent and inconclusive. Some
studies showed an inverse association (5–7), whereas others
showed a nonsignificant association in either direction (8–22). Of
note, evidence from randomized clinical trials was lacking. One
meta-analysis that focused on multiple food components briefly
reported the association between fish intake and pancreatic cancer
by quantitatively summarizing part of the existing literature on
this topic (23). The effect of LC-PUFA intake or the potential
influence of fish preparationmethods on pancreatic cancer risk was
not addressed. For the purpose of conducting a comprehensive
assessment of the overall association between fish or LC-PUFA
intake and pancreatic cancer and to provide an in-death discussion
on this topic, we performed a meta-analysis and systematic review
by summarizing and evaluating the relevant prospective cohort and
case-control studies in the existing literature.
Methods
Data sources and searches. We identified relevant prospective cohort
and case-control studies published in English-language journals that
reported the categorical association between LC-PUFA or fish intake with
pancreatic cancer through 15 February 2012 by searching the PubMed and
EMBASE database using the terms “fish,” “seafood,” “animal product*,”
“meat,” “fish oils,” “fatty acids, omega-3,” “omega-3 fatty acids,” “n-3
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fatty acids,” “n3 fatty acids,” “dietary fats,” and “pancreatic neoplasms,”
“pancreatic cancer,” “pancreatic adenocarcinoma*,” “pancreatic tumor,”
“pancreatic tumors,” “pancreatic islet” and “epidemiologic studies,” and
“cohort” or “case-control” (a detailed search history is provided in the
Supplemental Text). We also searched the reference list from retrieved
articles for more information. In addition, we included our de novo results
for this meta-analysis by analyzing data from the VITamins And Lifestyle
(VITAL) study (24). A review protocol is not available for this study.
Study selection. In general, articles were qualified for inclusion if they
were either cohort studies or case-control studies that reported HR, OR,
or other ratio estimates and corresponding 95% CI of pancreatic cancer
risk relating to fish or LC-PUFA intake, or such information can be
recalculated based on the available information in the primary studies We
also included cohort studies that evaluated fish intake and pancreatic
cancermortality. An unpublished studywas also identified. Two reviewers
(B.Q. and P.X.) independently assessed the eligibility of each study, and
disagreements were resolved by group discussion. The included cohort
studies involved sample sizes ranging from 61,433 to 525,473 and with
participants aged$35 y. Usual fish or fish oil intake was assessed by FFQ
for each study. The majority of the outcomes were confirmed by the
International Classification of Disease (ICD) (9th or 10th revision) or
International Classification of Disease for Oncology (ICD-O) (2nd or 3rd
edition).
Data extraction and quality assessment. The data we collected
included the first author’s name, year of publication, country of origin,
participants’ age (range, mean, or median), proportion of men, exposure
assessment, categories of fish or LC-PUFA intake, outcome confirmation,
and adjusted covariates for either type of study. We also extracted data on
numbers of participants and events, mean or median years of follow-up,
and HR and 95% CI of pancreatic cancer for the highest consumption of
fish or LC-PUFA intake versus the lowest exposure category from cohort
studies, as well as numbers of cases and controls, and OR and 95% CI of
pancreatic cancer from case-control studies. HR or OR were transformed
to their natural logarithms (ln), and the 95% CI was used to calculate the
corresponding SE. Two of the authors (B.Q. and P.X.) independently
assessed each study and extracted data from eligible studies. Discrepancies
were solved by group discussion.
The risk of bias in individual studies was ascertained by 2 authors
(B.Q. and P.X.) based on 1) whether exposure was assessed by using a
validated tool, 2) whether the case was confirmed by International
Classification of Diseases codes, 3) whether the response rate was.60%,
or 4) whether the participants with other types of cancer (except for
nonmelanoma skin cancer) diagnosed prior to baseline were excluded.
Data synthesis and analysis.HR andORwere our principal summary
measures. We pooled HR or OR estimates from the highest and lowest
categories of each study weighted by the inverse of the variance by using
a random-effects model (26), and evaluated the statistical heterogeneity
by calculating the I2 statistic. Among cohort studies, we also computed
the trend from the ln HR across categories of fish consumption by using
the median or mean value of each category (25,26). We rescaled the unit
to be a one-serving/wk increase of fish intake assuming one standard
portion size of fish intake is 105 g (27). When the uppermost boundary of
fish intake was open-ended, we assigned the value to be the lower bound
plus the width of the closest category (28). If the fish intake among
categories was unknown, we estimated the amount from studies using
the same cohort and consumption categories. We used Egger’s regression
asymmetry test to detect the presence of publication bias (29). We also
performed sensitivity analyses to detect the potential nonlinear relation
between fish intake and pancreatic cancer by replacing the highest
category with other categories, and to test if the results were driven by
any single study or were influenced by any identified study quality
criteria. The main findings were repeated by using a fixed-effects model.
We also conducted subgroup analyses in cohort studies stratified by
gender (male vs. female) and the location of the study (United States vs.
other countries). A 2-sided P value,0.05 was considered significant. All
analyses were performed by using STATA statistical software (version
11.0; STATA Corporation).
Results
We identified 133 potentially relevant publications from our
initial literature search (Supplemental Fig. 1). The database
created in our meta-analysis included 8 published independent
cohort studies (9–14,21,22) and one unpublished cohort study
(24), which comprised 1,209,265 participants and 3082 events
with a mean follow-up of 9.0 y (Table 1) and 10 independent
case-control studies (5–8,15–20) with 2514 cases and 18,779
controls (Table 2). Among these, 8 cohort studies (9–14,21,24)
and 9 case-control studies (5–7,15–20) reported results regard-
ing fish consumption, whereas 4 cohort studies (10,14,22,24) and
2 case-control studies (8,30) investigated the relation between LC-
PUFA intake and pancreatic cancer risk. Three cohort studies
(10,14,24) presented results for both fish and LC-PUFA intake.
Two case-control studies (19,30) used the same set of cases and
controls to investigate the risk of pancreatic cancer with fish or
LC-PUFA intake, respectively, and were counted as one indepen-
dent case-control study in our pooled data set (19). The other 2
case-control studies (6,7) that shared the same set of cases were
counted once in calculating the pooled case numbers.
Of the 9 cohort studies, 5 were from the United States and 4
from other countries. The number of participants ranged from
17,633 in the study by Zheng et al. (9) to 525,473 in that by
Thiébaut et al. (22). Two cohorts included only female partic-
ipants (11,13), and 2 included only men (9,10). The mean
follow-up was 9.0 y (range: 6.3–17.4 y). All cohort studies
examined fish or LC-PUFA intake by self-administered FFQ,
classified into 3 to 5 categories, and reported multivariable-
adjusted HR and 95% CI.
In the 10 included case-control studies, 3 were from North
America, 4 from Europe, and 3 from Asia. The cases ranged from
99 in the study by Norell et al. (15) to 532 in that by Chan et al.
(19). All case-control studies included both genders. Data on fish
or LC-PUFA intake were collected by FFQ, 4 of which were
validated. All case-control studies reported multivariable adjusted
OR and 95%CI except for one studywhich reported 90%CI (15).
The pooled HR from 8 cohort studies that reported results
on fish intake suggested that there was no significant reduction
in pancreatic cancer incidence for individuals with the highest
fish intake compared with those in the lowest intake category
[pooled HR: 0.98 (95% CI: 0.86, 1.12); Fig. 1, Supplemental
Table 1]. Similarly, the pooled HR of pancreatic cancer risk for a
one-serving/wk increase in fish consumption was 0.99 (95% CI:
0.96, 1.03). We did not find significant heterogeneity among
these 8 cohort studies (I2 = 0.0%, P = 0.73). In addition to
comparing 2 extreme categories, we performed sensitivity
analyses by replacing the highest category with other categories,
and the results were generally consistent. None of the studies
significantly influenced the summarized estimate, with pooled
HR ranging from 0.95 (95% CI: 0.83, 1.10) after excluding
Michaud et al. (11) to 1.05 (95% CI: 0.88, 1.26) after excluding
Nöthlings et al. (12). Excluding studies with a potential risk of
bias did not materially alter our findings (Supplemental Table 2;
results not shown). Our results were generally consistent
between the random-effects model and the fixed-effects model.
The Egger’s test showed little evidence of publication bias (P =
0.17). The results from subgroup analysis suggested that the null
association between fish consumption and pancreatic cancer risk
was not modified by gender or the location of the studies (United
States vs. other countries).
Similarly, the pooled results from 9 case-control studies did
not show a significant association between fish intake and
pancreatic cancer [pooled OR: 0.96 (95% CI: 0.76, 1.21) Fig. 2;
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Supplemental Table 3]. However, the heterogeneity among these
case-control studies was significant (P = 0.001), and 68.5%
heterogeneity may be explained by the variability between
studies. Nevertheless, Egger’s test did not indicate the presence
of publication bias (P = 0.64).
On the basis of the available data from either cohort or case-
control studies [pooled HR: 0.90 (95% CI: 0.65, 1.26); pooled
OR: 1.00 (95% CI: 0.79, 1.26)] comparing the highest intake
group with the lowest, LC-PUFA intake was not associated with
the risk of pancreatic cancer. The 4 cohort studies showed
evidence of significant heterogeneity (I2 = 77.3%, P = 0.004). No
strong evidence of publication bias was found among these
pooled cohorts (Egger’s test: P = 0.12).
Discussion
In this meta-analysis, which included 5596 cases of pancreatic
cancer and 1,228,064 noncases from 9 prospective cohort and
10 case-control studies, we did not find an inverse association of
fish or LC-PUFA consumption with risk of pancreatic cancer.
Gender or study location did not modify the results.
Our results are consistent with the findings from one previous
meta-analysis (23), which focused on multiple dietary compo-
nents and found no relation between fish intake and pancreatic
cancer from 5 independent prospective cohort studies and 3 case-
control studies, and one review (31), which focused on multiple
cancers and found no relation between LC-PUFA and the risk of
pancreatic cancer by quantitatively combining 2 cohort studies.
We performed an extensive literature search and captured more
published large-cohort studies as well as case-control studies of
both fish and LC-PUFA intake. Therefore, to our knowledge, our
results reflect the most comprehensive and updated findings from
the literature.
Most of the studies reporting the associations of fish or
LC-PUFA intake with risk of pancreatic cancer were primarily
designed to study either the effect of meat or dietary fat con-
sumption. Thus, they focused on total fish rather than different
species of fish or different preparation methods. This limitation
might contribute to the null findings in the primary studies and
this meta-analysis. Fish can be served in many ways, such as
fresh, broiled, baked, salted, or fried. Fish preparation methods
may alter the relation between fish intake and pancreatic cancer
FIGURE 2 Multivariable-adjusted OR
and 95% CI of pancreatic cancer risk for
fish consumption (highest vs. lowest)
from 9 case-control studies (arranged
according to the study year). The pooled
estimates were obtained by using a
random-effects model. Dots indicate the
adjusted OR of individual studies by
comparing participants in the highest with
those in the lowest fish consumption
group. Sizes of the shaded squares are
proportional to the percent weight of
each study. The diamond data markers
indicate the pooled OR and 95% CI.
FIGURE 1 Multivariable-adjusted HR
and 95% CI of pancreatic cancer risk for
fish consumption (highest vs. lowest)
from 8 prospective cohort studies (ar-
ranged according to study year). The
pooled estimates were obtained by using
a random-effects model. Dots indicate
the adjusted HR of individual studies by
comparing participants in the highest with
those in the lowest fish consumption
group. Sizes of the shaded squares are
proportional to the percentage weight of
each study. The diamond data markers
indicate the pooled HR and 95% CI.
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by changing the lipid profile and by generating unexpected
chemicals with the use of certain cooking methods. Frying, in
particular, was found to considerably reduce the amount of LC-
PUFA in fish (32). Deep-frying could generate trans-fatty acids,
oxidized lipids, or food mutagens such as heterocyclic amines
and benzo(a)pyrene, which may promote carcinogenesis and
which was found to be associated with elevated pancreatic cancer
risk (33–36). In our meta-analysis, only 2 previously published
case-control studies (15,18) briefly conducted separate analyses on
fish preparation methods. The case-control study by Ohba et al.
(18) indicated that raw fish intake significantly reduced the risk of
pancreatic cancer. The case-control study by Norell et al. (15)
found that fried/grilled fish consumption may attenuate or cancel
the potential benefit of fish consumption on pancreatic cancer risk.
With the realization of the need for evidence on the effect of fish
preparation methods as well as fish type on pancreatic cancer risk,
our de novo cohort study conducted a relative thorough separate
analysis on both fish preparation methods and fish types (24). Our
results suggested that nonfried fish but not total fish intake was
inversely associated with incident pancreatic cancer. Although the
limited number of studies did not allow us to perform a subgroup
analysis, results from the 3 studies discussed previously may
indicate the beneficial effect of raw or nonfried fish on pancreatic
cancer prevention. Further studies are clearly warranted to focus
on the different fish preparation methods and their potentially
different associations with pancreatic cancer risk.
Although LC-PUFA are believed to be the key nutrients in fish
responsible for the potential benefits of fish consumption, fish is a
combination of LC-PUFA and other nutrients as well as contam-
inants (37). The presence of mercury, dioxins, and polychlorinated
biphenyls in some fish species has been a public concern because
of their potential harm to human health. Because methylmercury
can be readily absorbed in tissue and bioaccumulate in the aquatic
food chains and food webs, larger and longer-living fish such
as sword-fish may have higher tissue concentrations of methyl-
mercury than shorter-living fish such as salmon (38). Although
data in humans are currently very limited with regard to mercury
exposure and cancer risk, animal studies have suggested that
methylmercury may lead to kidney tumors, whereas inorganic
mercuric chloride might increase the risk of several types of other
tumors (39). Polychlorinated biphenyls and dioxins, believed to
be carcinogenic on the basis of both animal experiments and
human studies (40), are also present in fish and shellfish (38). In
addition, diarrhetic shellfish poisoning toxins, a tumor agent that
may accumulate in shellfish, were recently hypothesized to
increase the risk of colorectal cancer (41). The finding from a
large cohort study that shellfish consumption increased the risk of
colorectal cancer risk was in agreement with this hypothesis (42).
Therefore, combining shellfish with other fish species might also
attenuate the potential beneficial effect of other nonfried fish on
pancreatic cancer development. Our unpublished cohort study
supported this hypothesis in which we found a moderate positive
association between shellfish intake and the incidence of pancre-
atic cancer (39).
Overall, it might be speculated that mixing all fish species and
preparation methods may have masked the potential inverse
association of fish intakewith pancreatic cancer risk. An extensive
analysis of fish species and preparation method with pancreatic
cancer risk is needed in the future.
Our meta-analysis has several merits. First, our quantitative
assessment separately analyzed cohort and case-control studies.
The included cohort studies comprised .1.2 million men and
women with a wide age range. All of the included cohort studies
had large sample sizes and long-term follow-up, which provided
high statistical power to estimate the relation between fish intake
and pancreatic cancer risk. Because conducting randomized
clinical trials might be impractical for prolonged compliance to the
assigned amount of fish intake, meta-analyses using prospective
cohort studies are considered to be a powerful tool in evaluating
the long-term association between fish intake and the risk of
pancreatic cancer. Second, we separately analyzed the relation of
pancreatic cancer risk with fish and LC-PUFA consumption in this
study. Because none of the included published studies specified that
the use of fish oil supplements contributed to total LC-PUFA,
dietary LC-PUFA can be viewed as a surrogate marker for fish
consumption when LC-PUFA level is directly calculated from fish
intake. The consistent results between fish and LC-PUFA strength-
ened our findings.
We performed sensitivity and subgroup analyses for cohort
studies in this meta-analysis. Our results did not materially change
when any single study or low-quality study was excluded. The null
association between fish consumption and pancreatic cancer risk
did not differ by gender or by the location of the studies. All except
for one cohort study defined their cases as exocrine pancreatic
cancer, which is where 95% of all pancreatic neoplasms start.
Solely studying the exocrine malignancies was considered appro-
priate, because the etiology of pancreatic endocrine tumor may be
different from that of exocrine tumor. When both univariate and
multivariate models were available from one study, we selected
results from maximum-controlled models.
Our study also had a few limitations. First, because the
different exposure measurement scale used in the included
studies and the information provided were not detailed enough
to allow standardization of fish intake, our analysis primarily
considered the highest versus the lowest exposure category,
which prevented us from evaluating the nonlinear association.
Nevertheless, the consistent finding from sensitivity analyses
that replaced the highest category with other categories
suggested that a U-shaped relation between fish and pancreatic
cancer was unlikely. Our summarized results were subject to the
limitations of any review in that the study characteristics,
exposure categories, and outcome diagnosis were not the same
across studies, and the inherit flaw of any observational study is
that there is uncontrolled or residual confounding that might
have biased the result. Although Egger’s regression asymmetry
test did not suggest a substantial publication bias (P = 0.17), a
potential bias resulting from the exclusion of studies published
in other languages (if any) was possible.
In summary, our meta-analysis of all relevant cohort and
case-control studies indicated that there is no association
between fish or fish oil consumption and the risk of pancreatic
cancer. From a public health perspective, we did not find solid
evidence to promote the intake of fish or fish oil supplements for
pancreatic cancer prevention. However, evidence for the effect
of different fish species and preparation methods on the risk
of pancreatic cancer is also lacking. To fully understand the
association between fish intake and pancreatic cancer, further
studies that consider fish subgroups (e.g., nonfried fish, fried fish,
and shellfish) and that adjust for mercury and other unhealthy
constituents in fish, if possible, are required. Although evidence
from this meta-analysis does not show a positive relation between
fish consumption and the primary prevention of pancreatic
cancer, our results should not alter the fact that fish is an overall
healthy food.
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